0:0010:13

Supercharging the Clinical Trial Process Through the Power of AI

Jennifer Bittinger 10:13 2023

One drug takes 12 to 15 years to approve, and AI is starting to cut it

Getting a single drug from research to regulatory approval still takes 12 to 15 years and at least $1 billion, and on average 40 to 50% of clinical trial data and documentation contains errors. Those costs land in every patient's pocketbook. Jennifer Bittinger, President of AI company Narrativa, helped automate every patient narrative in a Leukemia & Lymphoma Society trial bound for the FDA. What made that possible, and why does she credit her competitors?

Learn the three principles that turned a pandemic-era crisis into AI-written regulatory documents

Watch on YouTube

In short

Jennifer Bittinger, President of Narrativa, explains how natural language generation can automate clinical trial regulatory documentation to cut timelines, costs and human error. She frames the work around three principles for disruptors: don't fear disrupting the process, treat crisis as opportunity, and let competitors sharpen you.

“And number three, this is not common, but you need to love your neighbor embrace your competitors and let them sharpen you to greatness.”
“So we needed competitors to help educate the market about AI.”

What you will learn

  • Explain how AI developed from a 1951 program through supercomputers and processing chips to today's automation tools.
  • Identify the three core problems in clinical trial documentation: long timelines, inflated budgets and high error rates.
  • Apply a 'crisis means opportunity' mindset by running toward an industry problem with a concrete solution.
  • Use competitors to educate a new market, benchmark your pricing and push innovation forward.
  • Recognize how natural language generation can turn clinical trial data into patient narratives and regulatory documents.

Key takeaways from the speaker

  • 1. The Decade of Artificial Intelligence: Don’t be afraid to disrupt the process
  • 2. Crisis also means Opportunity: Run towards the problem and provide the solution
  • 3. Love Your Neighbor: Embrace Your Competitors and Let Them Sharpen You to Greatness

Details

Level
Beginner
Format
Lightning talk
Technical depth
Introductory technical
For
All career stages
Length
10:13
Published
June 2023

Questions this talk answers

Why does bringing a drug to market take so long and cost so much?

Bittinger says it takes 12 to 15 years and at least $1 billion to $1.5 billion per drug, and that 40 to 50% of clinical trial data and documentation contains errors because so many trials run at once.

How can AI help speed up clinical trials?

Narrativa uses natural language generation to turn mountains of clinical trial data into patient narratives and regulatory documents through a no-code SaaS platform. She cites at least a 65% reduction in time when the documentation is automated.

Is artificial intelligence a new technology?

No. She traces the first AI program to 1951 and Christopher Strachey, followed by the supercomputer age of the 1960s to 1980s and the processing chips of the 1990s.

Why should a company embrace its competitors?

Competitors helped Narrativa educate a market unfamiliar with AI, showed it how to price, and drive innovation for the whole industry.

What milestone has AI-generated regulatory documentation reached?

Narrativa automated all patient narratives for a trial with the Leukemia & Lymphoma Society, which she says was due to go to the FDA as their first clinical trial with fully AI-generated regulatory documentation.

About this talk

With the rapid increase of global pandemics, epidemics and developing nations needing more assistance with healthcare and pharmaceuticals, the Life Sciences Industry is at a pivotal moment in time where the advancements in artificial intelligence (AI) can help to speed up the time it takes for drugs to get to market while reducing cost and mitigating risk. Due to newly passed legislation to reduce the cost of pharmaceuticals and the immediate need for vaccines and pharmaceuticals the world experienced during the COVID-19 Pandemic, AI is now the most prominent disruptor of the Life Sciences Industry.

Topics

Related talks

Browse the library